Market Bounce - How To Capitalize
By
Admin
Wall Street Warrior Presents ⮕ ⮕ ⮕
If you look at the news right now … it seems like everything's awful. The CEO of Target announced a rise in violent crime. It's costing the company millions. Read more here. Investment bank UBS expects a $17 billion fallout from the emergency Credit Suisse rescue. Here are the details. And the debt ceiling issue remains unsolved. Although, it's reported a deal could come by the end of the week. Here's a video with more information … |
But remarkably, despite all the bad news, major indices are pushing higher today. The S&P 500 ETF Trust (NYSE: SPY) has been consolidating above $410 for almost two weeks. The chart below shows prices breaking through resistance … |
We're approaching highs for 2023. It's important to remember, we don't know which direction prices will go. And we're not trying to speculate. But the bullish volatility today is something to be grateful for. And it's possible the momentum carries over into our low-priced niche. |
|
|
Most won't see this breakout coming |
|
|
Speaking of low-priced opportunities … One of the biggest movers today has been Immutep Limited (NASDAQ: IMMP). This morning it announced bullish lung cancer data. And it certainly helps that biotech stocks have been red hot. So far the price managed to spike over 140%. And one of the key factors pointing to this move is its history of similar spikes. Past runners can run again. IMMP launched over 260% in 2020. Keep this ticker on your watchlist for the next few days. The move could continue. Here's the chart of today's price action … |
Get ready for more volatility towards the end of the week. And keep an eye out for more former runners on the move with news. |
|
|
Looking for more Daily Stock News? Click the link below to claim daily Dollar Stock Reports: |
|
|
Guardian Financial Publishing 3571 Far West Blvd Austin, TX 78731 United States This email was sent to diansastroxz.forex@blogger.com. Don't want to receive these emails anymore? Unsubscribe Privacy Policy | Terms | Risk Disclosure |
|
|
|
Related Posts
There is no other posts in this category.
Post a Comment
Post a Comment